NVCR: Growth in oncology franchises, global expansion, and profitability targets drive future outlook
Management outlined renewed growth in GBM, strategic launches in pancreatic and lung cancer, and disciplined cost controls. Global expansion is underway, with strong progress in Europe and Japan, and profitability is targeted by year-end.Based on NovoCure Limited [NVCR] Morgan Stanley 24th Annual G…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.